Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 315 matches for

Congratulations to Simon Leedham BSc PhD QMUL, MB BS London, FRCP, Professor of Gastroenterology and Wellcome Trust Senior Research Fellow in Clinical Science in the Wellcome Trust Centre for Human Genetics, has been appointed to the Professorship of Molecular and Population Genetics in the Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine. He took up the post on 1 October 2020 and will be a Fellow of Queen's College, Oxford.

portrait of Simon Leedham

Nigeria rolls out new Oxford R21 malaria vaccine

On Thursday, Nigeria announced the regulatory approval and launch of the new R21/Matrix-M™ malaria vaccine that will be freely administered to recipients. This marks a significant milestone in the country’s fight against the deadly disease.

Developing the first cancer prevention vaccine for Lynch syndrome

Scientists from the Centre for Human Genetics at Nuffield Department of Medicine are taking the initial steps in developing the UK’s first vaccine to prevent cancer in people with Lynch syndrome, thanks to funding from Cancer Research UK.

PSI collaborates with Oxford's History of Science Museum on new exhibition

The Pandemic Sciences Institute, in collaboration with the Ethox Centre, has supported a new exhibition at Oxford’s History of Science Museum. The exhibition, entitled "A Healthy Future for All?", explores the science driving advancements in healthcare

Côte d’Ivoire becomes first nation to deploy R21 malaria vaccine

Côte d’Ivoire will become the first country to roll-out the new R21/Matrix-M™ vaccine with the first child vaccinated in Abidjan, marking a critical step and historic milestone in the global fight against malaria. 15 African countries are expected to introduce malaria vaccines with Gavi support in 2024, and countries plan to reach around 6.6 million children with the malaria vaccine in 2024 and 2025. The new vaccine has been authorised by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments.

Caesar Atuire appointed International Association of Bioethics President

Many congratulations to Dr Caesar Atuire who has been appointed President of the International Association of Bioethics.

Bangladesh Health Minister visits the Centre for Medicines Discovery

The Minister of Health and Family Welfare of Bangladesh, the Honourable Dr Samanta Lal Sen, and the Bangladesh High Commissioner to the UK, Her Excellency Ms Saida Muna Tasneem, paid a visit to the Centre for Medicines Discovery at NDM last week.

Pandemic computer simulations to guide future vaccine trials

Researchers from the Pandemic Sciences Institute at NDM are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.

Academy of Medical Sciences elects two NDM researchers as new Fellows

The Academy of Medical Sciences has elected two medical scientists from the Nuffield Department of Medicine to its fellowship in 2024.

NDM scientists elected as Royal Society Fellows

Two academics from the Nuffield Department of Medicine have joined the Royal Society as Fellows.

Prof Yang Shi elected to the US National Academy of Sciences

Professor Yang Shi from the Ludwig Institute for Cancer Research at NDM has been elected as a member of the National Academy of Sciences in the United States.

Melanoma research in the Ludwig Institute for Cancer Research

For Skin Cancer Awareness Month, the Ludwig Institute for Cancer Research looks at recent research into melanoma from Professors Richard White, Professor of Genetics, and Colin Goding, Professor of Oncology.

Unveiling of Medawar Nobel Prize medal

The Oxford immunology community celebrated the donation of Sir Peter Medawar’s Nobel Prize medal to the University.

Record number of patients enrolled in a landmark plague trial

A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.

The potential of the R21/Matrix vaccine to redefine malaria prevention

Researchers from the Jenner Institute at NDM will present new exciting data on the R21/Matrix-M malaria vaccine during the 8th Pan-African Malaria Conference, in collaboration with the Rwandan Ministry of Health and the Rwanda Biomedical Centre.

Chinese ambassador visits CAMS Oxford Institute

The Chinese Ambassador to the United Kingdom, His Excellency Zheng Zeguang, visited the University of Oxford last week, where he promoted deeper educational exchanges between China and the UK. During the visit, Zheng met with Irene Tracey, Vice-Chancellor of the university, and had an in-depth discussion on the university’s collaboration with Chinese counterparts.

Francesco Boccellato receives Lee Placito Research Fellowship

Dr Francesco Boccellato, Leadership Fellow at the Oxford Branch of the Ludwig Institute for Cancer Research has recently been awarded the Lee Placito Research Fellowship in Gastrointestinal Cancer.

Oxford hosts Belgian vaccine experts

Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.

OUCRU celebrates World Health Worker Week 2024

In the first week of April each year, the global community comes together to celebrate health workers, the backbone of the health industry and society.

Developing the world's first lung cancer vaccine

Researchers at the Nuffield Department of Medicine, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The group includes Professor Tim Elliott, Kidani Professor of Immuno-oncology at NDM.

CMD partners with Ono Pharmaceutical Co for translational research

The Centre for Medicines Discovery (CMD) at NDM, has recently partnered with Ono Pharmaceutical Co (Ono) to validate and develop novel targets in a bid to discover innovative medicines.

Load More

Similar stories